Table of Contents Table of Contents
Previous Page  16 / 18 Next Page
Information
Show Menu
Previous Page 16 / 18 Next Page
Page Background

Page 43

Note:

O c t o b e r 1 5 - 1 6 , 2 0 1 8 | T o k y o , J a p a n

Obesity Congress 2018, Diabetes Congress 2018 & Vaccines Congress 2018

Biomedical Research

|

ISSN: 0976-1683

|

Volume 29

2

nd

WORLD OBESITY CONGRESS

2

nd

WORLD VACCINES AND IMMUNOLOGY CONGRESS

&

&

DIABETES AND ENDOCRINOLOGY

International Conference on

Joint Event on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Gerardo Guillén et al., Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C5-013

VIRUS LIKE PARTICLES AND

NUCLEOPARTICLES AS A VACCINE

CANDIDATE

Gerardo Guillén, Aguilar JC, Hermida L, Gil L, Penton E

and

Iglesias E

Center for Genetic Engineering and Biotechnology, Cuba

T

he existing vaccines are mainly limited to the microorganisms we can cul-

ture and produce and/or to those whose killing is mediated by humoral

response (antibody mediated). It has been more difficult to develop vaccines

capable to induce functional cellular response needed to prevent or cure

chronic diseases. New strategies should be considered in the improvement

of cell-based immune responses to prevent and control the infections and

eventually clear the virus. This work present preclinical and clinical results

with vaccine candidates against dengue virus, HBV and HIV based on virus

like particles (VLPs) and virus like nucleoparticles (VLNs) able to stimulate

mucosal as well as systemic immunity. Particles based on envelope or nucle-

ocapsid viral proteins induce a strong immune response after mucosal or sys-

temic administration in mice, non-human primates and humans. In addition,

the immune response obtained was biased in a Th1 sense.

Gerardo Guillén is a Biomedical Research Director at the

Center for Genetic Engineering and Biotechnology (CIGB)

in Havana, have more than 170 papers and 44 patents

published on vaccinology, biotechnology, infectious dis-

eases and pharmaceutical development. He has been

honored with 47 annual awards of Cuban Academy of

Science for scientific results, the Third World Academy

of Science award on Biology, the CJ Finlay Medal of the

Cuban State Council, awarded for upstanding results

on Science and the patent award of the World Office of

Intellectual Property. He is also the member of several

editorial boards. He is the member of the Scientific Ex-

pert Committees of the BioCubaFarma, the CIGB and the

Center for Tropical Medicine IPK.

gerardo.guillen@cigb.edu.cu

BIOGRAPHY